Intrinsic Value of S&P & Nasdaq Contact Us

Fulcrum Therapeutics, Inc. FULC NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
64/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$20.57
+160.4%

Fulcrum Therapeutics, Inc. (FULC) has 5 identified peers for comparison in the Healthcare sector. Peers include BYSI, MIRM, PHAT, RAPT, STOK.

FULC has a market capitalization of $427.48M, compared to an average peer market cap of $1.8B. FULC is notably smaller than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message